Gramine: A Vasorelaxing Alkaloid Acting on 5-HT_2A Receptors

Abstract

The vascular effects of gramine on resistance vessels were evaluated, in particular as regards the 5-hydroxytryptamine (5-HT) system. We compared the action of gramine with that of ketanserin, a 5-HT_2A antagonist; both compounds induced concentration-dependent relaxation in precontracted arterial rings. Also, the 5-HT concentration-effect curve shifted to the right in the presence of gramine, like ketanserin. These results suggest that gramine is a vasorelaxing agent acting mainly by antagonism at 5-HT_2A receptors.

References

• 1 Niemeyer H M, Roveri O A. Effects of gramine on energy metabolism on rat and bovine mitochondria.  Biochem Pharmacol. 1984;  33 2973-9
• 2 Lockhart B, Closier M, Howard K, Steward C, Lestage P. Differential inhibition of [³ H]-oxotremorine-M and [³ H]-quinuclinidyl benzylate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.  N-S Arch Pharmacol. 2001;  363 429-38
• 3 Pastuszewska B, Smulikowska S, Wasilewko J, Buraczewska L, Ochtabinska A, Mieczkowska A. et al . Response of animals to dietary gramine. I. Performance and selected hematological, biochemical and histological parameters in growing chicken, rats and pigs.  Arch Tierernahr. 2001;  55 1-16
• 4 Katz P S, Frost W N. Intrinsic neuromodulation in the Tritonia swim CPG: serotonin mediates both neuromodulation and neurotrasmission by the dorsal swim interneurons.  J Neuroph. 1995;  74 2281-94
• 5 Nishi K. The action of 5-hydroxytryptamine on chemoreceptor discharges of the cat’s carotid body.  Br J Pharmacol. 1975;  55 27-40
• 6 Ferlin M G, Chiarelotto G, Antonucci F, Caparrotta L, Froldi G. Mannich bases of 3H-pyrrolo[3,2-f]quinoline having vasorelaxing activity.  Eur J Med Chem. 2002;  37 427-34
• 7 Hoyer D, Clarke D E, Fozard J R, Harting P R, Martin G R, Mylecharane E J. et al . International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).  Pharmacol Rev. 1994;  46 157-203
• 8 Chinellato A, Froldi G, Caparrotta L, Ragazzi E. Pharmacological characterization of endothelial cell nitric oxide synthase inhibitors in isolated rabbit aorta.  Life Sci. 1998;  62 479-90
• 9 Van Nueten J M, Janssen A J, Van Beek J, Xhonneux R, Verbeuren T J, Vanhoutte P M. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT₂ serotonergic receptors.  J Pharmacol Exp Ther. 1981;  218 217-30
• 10 Wenting G J, Woittiez A J, Man In’t Veld A J, Schalekamp M A. 5HT, alpha-adrenoceptors and blood pressure effects of ketanserin in essential hypertension and autonomic insufficiency.  Hypertension. 1984;  6 100-9
• 11 Hedner T, Persson B. Experience with ketanserin and ritanserin in hypertensive patients.  J Cardiovasc Pharmacol. 1988;  11 (S1) 44-8
• 12 Iwata S, Saito S, Kon-ya K, Shizuri Y, Ohizumi Y. Novel marine-derived halogen-containing gramine analogues induce vasorelaxation in isolated rat aorta.  Eur J Pharmacol. 2001;  432 63-70